SlideShare a Scribd company logo
1 of 21
Download to read offline
Tuberculosis
Dr Sushma Singh
Social Internship Coordinator & Teacher Volunteer
(DOE GNCT DELHI)
Flow
Key Facts
Over View
Symptoms
Prevention
Diagnosis
Treatment
Multidrug-resistant TB
TB and HIV
Impact
Investment to end TB
WHO response
Dr Sushma Singh 2
Key Facts & Data
Dr Sushma Singh 3
Key Facts
â–Ş A total of 1.3 million people died from TB in 2022 (including 167 000 people with HIV).
Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS).
â–Ş In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, including
5.8 million men, 3.5 million women and 1.3 million children. TB is present in all countries and age
groups. TB is curable and preventable.
â–Ş Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat. Only
about 2 in 5 people with drug resistant TB accessed treatment in 2022.
â–Ş Global efforts to combat TB have saved an estimated 75 million lives since the year 2000.
â–Ş US$ 13 billion is needed annually for TB prevention, diagnosis, treatment and care to achieve the
global target agreed at the 2018 UN high level-meeting on TB.
â–Ş Ending the TB epidemic by 2030 is among the health targets of the United Nations Sustainable
Development Goals (SDGs).
Dr Sushma Singh 4
Over View
Tuberculosis
Over View
â–Ş Tuberculosis (TB) is an infectious disease that most often affects the lungs and is caused
by a type of bacteria. It spreads through the air when infected people cough, sneeze or
spit.
â–Ş Tuberculosis is preventable and curable.
â–Ş About a quarter of the global population is estimated to have been infected with TB
bacteria. About 5–10% of people infected with TB will eventually get symptoms and
develop TB disease.
â–Ş Those who are infected but not (yet) ill with the disease cannot transmit it. TB disease is
usually treated with antibiotics and can be fatal without treatment.
▪ In certain countries, the Bacille Calmette-Guérin (BCG) vaccine is given to babies or small
children to prevent TB. The vaccine prevents TB outside of the lungs but not in the lungs.
Dr Sushma Singh 6
Symptoms
coughing
, prolonged cough
Weakness
Weight loss
.
Fever
Night sweats
Chest Pain
Fatigue
Dr Sushma Singh 7
Symptoms
People with latent TB infection don’t feel sick and aren’t contagious. Only a small
proportion of people who get infected with TB will get TB disease and symptoms.
Babies and children are at higher risk.
Certain conditions can increase a person’s risk for tuberculosis disease:
diabetes (high blood sugar)
weakened immune system (for example, HIV or AIDS)
being malnourished
tobacco use.
Dr Sushma Singh 8
Symptoms
Unlike TB infection, when a person gets TB disease, they will have symptoms. These may be mild for many
months, so it is easy to spread TB to others without knowing it.
Common symptoms of TB:
prolonged cough (sometimes with blood)
chest pain
weakness
fatigue
weight loss
fever
night sweats.
The symptoms people get depend on where in the body TB becomes active. While TB usually affects the
lungs, it also affects the kidneys, brain, spine and skin.
Dr Sushma Singh 9
Flow of Presentation
Prevention
President
TB and HIV
VP Product
Diagnosis
Chief Executive Officer
Impact
SEO Strategist
Treatment
Chief Operations Officer
Investments to end TB
Product Designer
Multidrug-resistant TB
VP Marketing
WHO response
Content Developer
Dr Sushma Singh 10
Prevention
Follow these steps to help prevent tuberculosis infection and spread:
• Seek medical attention if you have symptoms like prolonged cough, fever and
unexplained weight loss as early treatment for TB can help stop the spread of
disease and improve your chances of recovery.
• Get tested for TB infection if you are at increased risk, such as if you have HIV or
are in contact with people who have TB in your household or your workplace.
• If prescribed treatment to prevent TB, complete the full course.
• If you have TB, practice good hygiene when coughing, including avoiding contact with
other people and wearing a mask, covering your mouth and nose when coughing or
sneezing, and disposing of sputum and used tissues properly.
Dr Sushma Singh 11
Diagnosis
WHO recommends the use of rapid molecular diagnostic tests as the initial diagnostic test in all persons
with signs and symptoms of TB.
1
Rapid diagnostic tests recommended by WHO include the Xpert MTB/RIF Ultra and Truant assays. These tests have
high diagnostic accuracy and will lead to major improvements in the early detection of TB and drug-resistant TB.
2
A tuberculin skin test (TST) or interferon gamma release assay (IGRA) can be used to identity people with infection.
3
Diagnosing multidrug-resistant and other resistant forms of TB (see multidrug-resistant TB section below) as well as
HIV-associated TB can be complex and expensive.
4
Tuberculosis is particularly difficult to diagnose in children.
Dr Sushma Singh 12
Treatment
• Tuberculosis disease is treated with antibiotics. Treatment is recommended for both TB infection and disease.
• The most common antibiotics used are:
• isoniazid
• rifampin
• pyrazinamide
• ethambutol
• streptomycin.
• To be effective, these medications need to be taken daily for 4–6 months. It is dangerous to stop the medications early
or without medical advice. This can allow TB that is still alive to become resistant to the drugs.
• Tuberculosis that doesn’t respond to standard drugs is called drug-resistant TB and requires more toxic treatment with
different medicines.
Dr Sushma Singh 13
Multidrug-resistant TB
Dr Sushma Singh 14
when TB medicines are used
inappropriately
emerges
a public health crisis and a health
security threat. Only about 2 in 5
people with drug resistant.
MDR-TB remains
(MDR-TB) is a form of TB caused by
bacteria that do not respond to
isoniazid and rifampicin, the 2 most
effective first-line
Multidrug-resistant tuberculosis
requires bacteriological confirmation of
TB and testing for drug resistance using
rapid molecular tests or culture methods.
WHO, detection of MDR/RR-TB
that do not respond to the most
effective second-line TB drugs
can leave patients with very
limited treatment options.
TB caused by bacteria
TB and HIV
▪ People living with HIV are 16 (uncertainty interval 14–18) times more likely to fall ill with
TB disease than people without HIV. TB is the leading cause of death among people with
HIV.
â–Ş HIV and TB form a lethal combination, each speeding the other's progress. Without
proper treatment, 60% of HIV-negative people with TB on average and nearly all HIV-
positive people with TB will die. In 2022, about 167 000 people died of HIV-associated
TB. The WHO African Region has the highest burden of HIV-associated TB. Overall in
2022, only 54% of TB patients known to be living with HIV were on antiretroviral
therapy (ART).
â–Ş WHO recommends a 12-component approach of collaborative TB-HIV activities,
including actions for prevention and treatment of infection and disease, to reduce deaths.
Dr Sushma Singh 15
Impact
Countries
â–Ş Tuberculosis mostly affects adults
in their most productive years.
However, all age groups are at
risk. Over 80% of cases and
deaths are in low- and middle-
income countries.
New Cases
• the largest number of new TB
cases occurred in WHO’s South-
East Asian Region (46%), followed
by the African Region (23%) and
the Western Pacific (18%). Around
87% of new TB cases occurred in
the 30 high TB burden countries,
with more than two-thirds of the
global total in Bangladesh, China,
Democratic Republic of the
Congo, India, Indonesia, Nigeria,
Pakistan and the Philippines.
TB ,HIV and Malnutrition
â–Ş Globally in 2022, there were
2.2 million new TB cases that
were attributable to
undernutrition, 0.89 million to
HIV infection, 0.73 million to
alcohol use disorders, 0.70 million
to smoking and 0.37 million to
diabetes.
Dr Sushma Singh 16
Investments to end
TB
UN
â–Ş US$ 13 billion are needed annually for TB prevention,
diagnosis, treatment and care to achieve global targets
agreed on at the UN high level-TB meeting.
US
• The United States Government is the largest contributor
of funding to the Global Fund and also the largest bilateral
donor. For research and development, according to the
Treatment Action Group, only US$ 1 billion were available
in 2022 of the US$ 2 billion required per year to
accelerate the development of new tools.
Dr Sushma Singh 17
WHO response
Dr Sushma Singh 18
1
WHO is working
closely with
countries, partners
and civil society in
scaling up the TB
response
2
providing global
leadership to end
TB through strategy
development
3
shaping the TB
research and
innovation agenda
4
developing and
promoting ethical
and evidence-based
policy options for
TB prevention
5
setting norms and
standards on TB
prevention and care
and promoting
Summary
Follow these steps to help prevent
tuberculosis infection and spread:
Dr Sushma Singh 19
â–Ş 1. Seek medical attention
2. Get tested for TB infection if you are at increased risk, such as if you have HIV or
are in contact with people who have TB in your household or your workplace.
3. If prescribed treatment to prevent TB, complete the full course.
4. If you have TB, practice good hygiene Special measures like respirators and
ventilation are important to reduce infection in healthcare and other institutions.
“
WHO
”
Thank you
Director of Education
Ladli Foundation
Principal
All Beneficiaries

More Related Content

Similar to Tuberculosis Facts and Prevention

Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesAbhishek Sunny
 
world tb day.pptx
world tb day.pptxworld tb day.pptx
world tb day.pptxgangai2
 
Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328MadhuSM4
 
24 March World Tuberculosis (TB) Day..pptx
24 March World Tuberculosis (TB) Day..pptx24 March World Tuberculosis (TB) Day..pptx
24 March World Tuberculosis (TB) Day..pptxshailesh sangle
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationSharanya Rajan
 
introduction-TB-text
introduction-TB-textintroduction-TB-text
introduction-TB-textDrDR47
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxDebdattaMandal5
 
Epidemiology of Tuberculosis
Epidemiology of TuberculosisEpidemiology of Tuberculosis
Epidemiology of Tuberculosissaheli chakraborty
 
Epidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosisEpidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosisDr.Hemant Kumar
 
Tuberclosis presentation
Tuberclosis presentationTuberclosis presentation
Tuberclosis presentationRajatAtri2
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxanjalatchi
 
Imunizare in infectii
Imunizare in infectiiImunizare in infectii
Imunizare in infectiiClaudinaCobzariu
 
Miss farida's presentation
Miss farida's presentationMiss farida's presentation
Miss farida's presentationMubashar Alam
 
TB Working Group_Kayt E_10.13.11
TB Working Group_Kayt E_10.13.11TB Working Group_Kayt E_10.13.11
TB Working Group_Kayt E_10.13.11CORE Group
 
Tuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungTuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungSamrat Gurung
 
Tuberculosis
TuberculosisTuberculosis
TuberculosisAlvin Parcon
 
introduction-to-tuberculosis-508c.pptx
introduction-to-tuberculosis-508c.pptxintroduction-to-tuberculosis-508c.pptx
introduction-to-tuberculosis-508c.pptxdebapriyamandal7
 

Similar to Tuberculosis Facts and Prevention (20)

Sam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciencesSam higgimbottom institute of agriculture technology and sciences
Sam higgimbottom institute of agriculture technology and sciences
 
world tb day.pptx
world tb day.pptxworld tb day.pptx
world tb day.pptx
 
Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328Epidemiology of tuberculosis... 98754328
Epidemiology of tuberculosis... 98754328
 
24 March World Tuberculosis (TB) Day..pptx
24 March World Tuberculosis (TB) Day..pptx24 March World Tuberculosis (TB) Day..pptx
24 March World Tuberculosis (TB) Day..pptx
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health Presentation
 
introduction-TB-text
introduction-TB-textintroduction-TB-text
introduction-TB-text
 
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptxepidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
epidemiologypreventionoftuberculosis-150912091236-lva1-app6892.pptx
 
Epidemiology of Tuberculosis
Epidemiology of TuberculosisEpidemiology of Tuberculosis
Epidemiology of Tuberculosis
 
Epidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosisEpidemiology & prevention of tuberculosis
Epidemiology & prevention of tuberculosis
 
Tuberclosis presentation
Tuberclosis presentationTuberclosis presentation
Tuberclosis presentation
 
tuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptxtuberculosis Day 2022 ppt.pptx
tuberculosis Day 2022 ppt.pptx
 
Imunizare in infectii
Imunizare in infectiiImunizare in infectii
Imunizare in infectii
 
END TB 2015 strategy
END TB 2015 strategyEND TB 2015 strategy
END TB 2015 strategy
 
Miss farida's presentation
Miss farida's presentationMiss farida's presentation
Miss farida's presentation
 
Presentation on HIV by Dr Sushma Singh
Presentation on HIV by Dr Sushma Singh Presentation on HIV by Dr Sushma Singh
Presentation on HIV by Dr Sushma Singh
 
Prevalence of Tuberculosis: Present Status and Overview of Its Control System...
Prevalence of Tuberculosis: Present Status and Overview of Its Control System...Prevalence of Tuberculosis: Present Status and Overview of Its Control System...
Prevalence of Tuberculosis: Present Status and Overview of Its Control System...
 
TB Working Group_Kayt E_10.13.11
TB Working Group_Kayt E_10.13.11TB Working Group_Kayt E_10.13.11
TB Working Group_Kayt E_10.13.11
 
Tuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat GurungTuberculosis uploaded by Samrat Gurung
Tuberculosis uploaded by Samrat Gurung
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
introduction-to-tuberculosis-508c.pptx
introduction-to-tuberculosis-508c.pptxintroduction-to-tuberculosis-508c.pptx
introduction-to-tuberculosis-508c.pptx
 

More from Directorate of Education Delhi

Anjali SKV Sector16 Rohini SWOT Analysis Social Internship Program
Anjali SKV Sector16 Rohini SWOT Analysis Social Internship ProgramAnjali SKV Sector16 Rohini SWOT Analysis Social Internship Program
Anjali SKV Sector16 Rohini SWOT Analysis Social Internship ProgramDirectorate of Education Delhi
 
Social Internship Program. Report #directorateofeducation #ladlifoundation
Social Internship Program. Report #directorateofeducation  #ladlifoundation Social Internship Program. Report #directorateofeducation  #ladlifoundation
Social Internship Program. Report #directorateofeducation #ladlifoundation Directorate of Education Delhi
 
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdf
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdfSWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdf
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdfDirectorate of Education Delhi
 
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh WASH( Water Sanitation and Hygiene) by Dr Sushma Singh
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh Directorate of Education Delhi
 

More from Directorate of Education Delhi (20)

Intern Neha Kumari SWOT analysis .
Intern Neha Kumari SWOT analysis .Intern Neha Kumari SWOT analysis .
Intern Neha Kumari SWOT analysis .
 
Anjali SKV Sector16 Rohini SWOT Analysis Social Internship Program
Anjali SKV Sector16 Rohini SWOT Analysis Social Internship ProgramAnjali SKV Sector16 Rohini SWOT Analysis Social Internship Program
Anjali SKV Sector16 Rohini SWOT Analysis Social Internship Program
 
Bhoomi(Skv sector 16 rohini) SWOT Analysis
Bhoomi(Skv sector 16 rohini) SWOT AnalysisBhoomi(Skv sector 16 rohini) SWOT Analysis
Bhoomi(Skv sector 16 rohini) SWOT Analysis
 
Social Internship Program. Report #directorateofeducation #ladlifoundation
Social Internship Program. Report #directorateofeducation  #ladlifoundation Social Internship Program. Report #directorateofeducation  #ladlifoundation
Social Internship Program. Report #directorateofeducation #ladlifoundation
 
Neeru SWOTAnalysis.pdf
Neeru SWOTAnalysis.pdfNeeru SWOTAnalysis.pdf
Neeru SWOTAnalysis.pdf
 
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdf
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdfSWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdf
SWOT ANALYSIS by Vinita Joshi, G.S.K.V Sec-16 Rohini Delhi.pdf
 
Mahak SWOTAnalysis.pptx
Mahak SWOTAnalysis.pptxMahak SWOTAnalysis.pptx
Mahak SWOTAnalysis.pptx
 
NaazmeenSWOTAnalysis.pptx
NaazmeenSWOTAnalysis.pptxNaazmeenSWOTAnalysis.pptx
NaazmeenSWOTAnalysis.pptx
 
MahiSWOTAnalysis.pdf
MahiSWOTAnalysis.pdfMahiSWOTAnalysis.pdf
MahiSWOTAnalysis.pdf
 
AyeshaSWOTAnalysis.PDF
AyeshaSWOTAnalysis.PDFAyeshaSWOTAnalysis.PDF
AyeshaSWOTAnalysis.PDF
 
AnnuSWOTAnalysis.pdf
AnnuSWOTAnalysis.pdfAnnuSWOTAnalysis.pdf
AnnuSWOTAnalysis.pdf
 
DeepaSWOTAnalysis.pdf
DeepaSWOTAnalysis.pdfDeepaSWOTAnalysis.pdf
DeepaSWOTAnalysis.pdf
 
soni SWOTAnalysis.pptx
soni SWOTAnalysis.pptxsoni SWOTAnalysis.pptx
soni SWOTAnalysis.pptx
 
Geetanjali SWOT Analysis.pdf
Geetanjali SWOT Analysis.pdfGeetanjali SWOT Analysis.pdf
Geetanjali SWOT Analysis.pdf
 
shivangi SWOTAnalysis.pdf
shivangi SWOTAnalysis.pdfshivangi SWOTAnalysis.pdf
shivangi SWOTAnalysis.pdf
 
JannatSWOTAnalysis.pptx
JannatSWOTAnalysis.pptxJannatSWOTAnalysis.pptx
JannatSWOTAnalysis.pptx
 
Sakshi SWOT Analysis S.K.V sec 16 rohini.pdf
Sakshi SWOT Analysis S.K.V sec 16 rohini.pdfSakshi SWOT Analysis S.K.V sec 16 rohini.pdf
Sakshi SWOT Analysis S.K.V sec 16 rohini.pdf
 
Khushboo SWOTAnalysis.pptx
Khushboo SWOTAnalysis.pptxKhushboo SWOTAnalysis.pptx
Khushboo SWOTAnalysis.pptx
 
Digital Empowerment. By Dr Sushma Singh
Digital Empowerment. By Dr Sushma SinghDigital Empowerment. By Dr Sushma Singh
Digital Empowerment. By Dr Sushma Singh
 
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh WASH( Water Sanitation and Hygiene) by Dr Sushma Singh
WASH( Water Sanitation and Hygiene) by Dr Sushma Singh
 

Recently uploaded

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 

Recently uploaded (20)

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 

Tuberculosis Facts and Prevention

  • 1. Tuberculosis Dr Sushma Singh Social Internship Coordinator & Teacher Volunteer (DOE GNCT DELHI)
  • 2. Flow Key Facts Over View Symptoms Prevention Diagnosis Treatment Multidrug-resistant TB TB and HIV Impact Investment to end TB WHO response Dr Sushma Singh 2
  • 3. Key Facts & Data Dr Sushma Singh 3
  • 4. Key Facts â–Ş A total of 1.3 million people died from TB in 2022 (including 167 000 people with HIV). Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS). â–Ş In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, including 5.8 million men, 3.5 million women and 1.3 million children. TB is present in all countries and age groups. TB is curable and preventable. â–Ş Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat. Only about 2 in 5 people with drug resistant TB accessed treatment in 2022. â–Ş Global efforts to combat TB have saved an estimated 75 million lives since the year 2000. â–Ş US$ 13 billion is needed annually for TB prevention, diagnosis, treatment and care to achieve the global target agreed at the 2018 UN high level-meeting on TB. â–Ş Ending the TB epidemic by 2030 is among the health targets of the United Nations Sustainable Development Goals (SDGs). Dr Sushma Singh 4
  • 6. Over View â–Ş Tuberculosis (TB) is an infectious disease that most often affects the lungs and is caused by a type of bacteria. It spreads through the air when infected people cough, sneeze or spit. â–Ş Tuberculosis is preventable and curable. â–Ş About a quarter of the global population is estimated to have been infected with TB bacteria. About 5–10% of people infected with TB will eventually get symptoms and develop TB disease. â–Ş Those who are infected but not (yet) ill with the disease cannot transmit it. TB disease is usually treated with antibiotics and can be fatal without treatment. â–Ş In certain countries, the Bacille Calmette-GuĂ©rin (BCG) vaccine is given to babies or small children to prevent TB. The vaccine prevents TB outside of the lungs but not in the lungs. Dr Sushma Singh 6
  • 7. Symptoms coughing , prolonged cough Weakness Weight loss . Fever Night sweats Chest Pain Fatigue Dr Sushma Singh 7
  • 8. Symptoms People with latent TB infection don’t feel sick and aren’t contagious. Only a small proportion of people who get infected with TB will get TB disease and symptoms. Babies and children are at higher risk. Certain conditions can increase a person’s risk for tuberculosis disease: diabetes (high blood sugar) weakened immune system (for example, HIV or AIDS) being malnourished tobacco use. Dr Sushma Singh 8
  • 9. Symptoms Unlike TB infection, when a person gets TB disease, they will have symptoms. These may be mild for many months, so it is easy to spread TB to others without knowing it. Common symptoms of TB: prolonged cough (sometimes with blood) chest pain weakness fatigue weight loss fever night sweats. The symptoms people get depend on where in the body TB becomes active. While TB usually affects the lungs, it also affects the kidneys, brain, spine and skin. Dr Sushma Singh 9
  • 10. Flow of Presentation Prevention President TB and HIV VP Product Diagnosis Chief Executive Officer Impact SEO Strategist Treatment Chief Operations Officer Investments to end TB Product Designer Multidrug-resistant TB VP Marketing WHO response Content Developer Dr Sushma Singh 10
  • 11. Prevention Follow these steps to help prevent tuberculosis infection and spread: • Seek medical attention if you have symptoms like prolonged cough, fever and unexplained weight loss as early treatment for TB can help stop the spread of disease and improve your chances of recovery. • Get tested for TB infection if you are at increased risk, such as if you have HIV or are in contact with people who have TB in your household or your workplace. • If prescribed treatment to prevent TB, complete the full course. • If you have TB, practice good hygiene when coughing, including avoiding contact with other people and wearing a mask, covering your mouth and nose when coughing or sneezing, and disposing of sputum and used tissues properly. Dr Sushma Singh 11
  • 12. Diagnosis WHO recommends the use of rapid molecular diagnostic tests as the initial diagnostic test in all persons with signs and symptoms of TB. 1 Rapid diagnostic tests recommended by WHO include the Xpert MTB/RIF Ultra and Truant assays. These tests have high diagnostic accuracy and will lead to major improvements in the early detection of TB and drug-resistant TB. 2 A tuberculin skin test (TST) or interferon gamma release assay (IGRA) can be used to identity people with infection. 3 Diagnosing multidrug-resistant and other resistant forms of TB (see multidrug-resistant TB section below) as well as HIV-associated TB can be complex and expensive. 4 Tuberculosis is particularly difficult to diagnose in children. Dr Sushma Singh 12
  • 13. Treatment • Tuberculosis disease is treated with antibiotics. Treatment is recommended for both TB infection and disease. • The most common antibiotics used are: • isoniazid • rifampin • pyrazinamide • ethambutol • streptomycin. • To be effective, these medications need to be taken daily for 4–6 months. It is dangerous to stop the medications early or without medical advice. This can allow TB that is still alive to become resistant to the drugs. • Tuberculosis that doesn’t respond to standard drugs is called drug-resistant TB and requires more toxic treatment with different medicines. Dr Sushma Singh 13
  • 14. Multidrug-resistant TB Dr Sushma Singh 14 when TB medicines are used inappropriately emerges a public health crisis and a health security threat. Only about 2 in 5 people with drug resistant. MDR-TB remains (MDR-TB) is a form of TB caused by bacteria that do not respond to isoniazid and rifampicin, the 2 most effective first-line Multidrug-resistant tuberculosis requires bacteriological confirmation of TB and testing for drug resistance using rapid molecular tests or culture methods. WHO, detection of MDR/RR-TB that do not respond to the most effective second-line TB drugs can leave patients with very limited treatment options. TB caused by bacteria
  • 15. TB and HIV â–Ş People living with HIV are 16 (uncertainty interval 14–18) times more likely to fall ill with TB disease than people without HIV. TB is the leading cause of death among people with HIV. â–Ş HIV and TB form a lethal combination, each speeding the other's progress. Without proper treatment, 60% of HIV-negative people with TB on average and nearly all HIV- positive people with TB will die. In 2022, about 167 000 people died of HIV-associated TB. The WHO African Region has the highest burden of HIV-associated TB. Overall in 2022, only 54% of TB patients known to be living with HIV were on antiretroviral therapy (ART). â–Ş WHO recommends a 12-component approach of collaborative TB-HIV activities, including actions for prevention and treatment of infection and disease, to reduce deaths. Dr Sushma Singh 15
  • 16. Impact Countries â–Ş Tuberculosis mostly affects adults in their most productive years. However, all age groups are at risk. Over 80% of cases and deaths are in low- and middle- income countries. New Cases • the largest number of new TB cases occurred in WHO’s South- East Asian Region (46%), followed by the African Region (23%) and the Western Pacific (18%). Around 87% of new TB cases occurred in the 30 high TB burden countries, with more than two-thirds of the global total in Bangladesh, China, Democratic Republic of the Congo, India, Indonesia, Nigeria, Pakistan and the Philippines. TB ,HIV and Malnutrition â–Ş Globally in 2022, there were 2.2 million new TB cases that were attributable to undernutrition, 0.89 million to HIV infection, 0.73 million to alcohol use disorders, 0.70 million to smoking and 0.37 million to diabetes. Dr Sushma Singh 16
  • 17. Investments to end TB UN â–Ş US$ 13 billion are needed annually for TB prevention, diagnosis, treatment and care to achieve global targets agreed on at the UN high level-TB meeting. US • The United States Government is the largest contributor of funding to the Global Fund and also the largest bilateral donor. For research and development, according to the Treatment Action Group, only US$ 1 billion were available in 2022 of the US$ 2 billion required per year to accelerate the development of new tools. Dr Sushma Singh 17
  • 18. WHO response Dr Sushma Singh 18 1 WHO is working closely with countries, partners and civil society in scaling up the TB response 2 providing global leadership to end TB through strategy development 3 shaping the TB research and innovation agenda 4 developing and promoting ethical and evidence-based policy options for TB prevention 5 setting norms and standards on TB prevention and care and promoting
  • 19. Summary Follow these steps to help prevent tuberculosis infection and spread: Dr Sushma Singh 19
  • 20. â–Ş 1. Seek medical attention 2. Get tested for TB infection if you are at increased risk, such as if you have HIV or are in contact with people who have TB in your household or your workplace. 3. If prescribed treatment to prevent TB, complete the full course. 4. If you have TB, practice good hygiene Special measures like respirators and ventilation are important to reduce infection in healthcare and other institutions. “ WHO ”
  • 21. Thank you Director of Education Ladli Foundation Principal All Beneficiaries